中 文  |  English
Your present location:Home > Our History > Drug development

Drug development

KR Anticancer Drug Research Institute
 


  The Anticancer Research Institute is dedicated to the research and production of chitosan oligosaccharide-based anti-cancer drug Aidejia, which is a kind of anti-metabolic substances, composed of various natural antibiotics and anticancer agents. It can serve both as a early diagnostic agent for cancers, and an effective therapeutic agent for cancers, which has important significance for glycobiology and sugar medicine. After several years of unremitting research, and through a large number of animal and clinical experiments, chitosan oligosaccharide-based anti-cancer drug Aidejia has become the best way for cancer treatment, featuring fast effect, short medicine time, no pain, no side effects, etc., being highly recognized by the glycobiology circle and the medicine circle.

  This is a silent and selfless team that seeks the value of life in their day-to day experimental analysis and data collection, devoting themselves with loyalty and sincerity.
  This is a rigorous, meticulous, serious and realistic team, who turn boring experiments into beautiful notes, to compose magnificent symphonies of health. They turn ordinary things into the extraordinary. Each group of beating data is permeated with their blood and sweat.
  This is a pioneering team that forges ahead with no regrets. They challenge the common enemy of human health - cancer, focusing their efforts on the trial production of the anti-cancer drug Aidejia, and keeping pace with the international research results in the medical world, to open up new areas for human health.